Rankings
▼
Calendar
SMMT Q4 2021 Earnings — Summit Therapeutics Inc. Revenue & Financial Results | Market Cap Arena
SMMT
Summit Therapeutics Inc.
$12B
Q4 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$251,000
+35.7% YoY
Gross Profit
$251,000
100.0% margin
Operating Income
-$26M
-10377.3% margin
Net Income
-$26M
-10253.0% margin
EPS (Diluted)
$-0.28
QoQ Revenue Growth
-80.8%
Cash Flow
Operating Cash Flow
-$9M
Free Cash Flow
-$9M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$113M
Total Liabilities
$30M
Stockholders' Equity
$83M
Cash & Equivalents
$72M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$251,000
$185,000
+35.7%
Gross Profit
$251,000
$185,000
+35.7%
Operating Income
-$26M
-$14M
-92.2%
Net Income
-$26M
-$14M
-89.1%
Revenue Segments
License and Service
$251,000
100%
Geographic Segments
Latin America
$251,000
100%
← FY 2021
All Quarters
Q1 2022 →